These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18722100)

  • 1. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study.
    Lamprecht B; Schirnhofer L; Kaiser B; Buist S; Studnicka M
    Respir Med; 2008 Dec; 102(12):1833-8. PubMed ID: 18722100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
    Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
    Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.
    Miravitlles M; Ferrer M; Pont A; Luis Viejo J; Fernando Masa J; Gabriel R; Jiménez-Ruiz CA; Villasante C; Fernández-Fau L; Sobradillo V
    Respir Med; 2005 Aug; 99(8):985-95. PubMed ID: 15950139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.
    Celli BR; Halbert RJ; Nordyke RJ; Schau B
    Am J Med; 2005 Dec; 118(12):1364-72. PubMed ID: 16378780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies.
    Hagstad S; Ekerljung L; Lindberg A; Backman H; Rönmark E; Lundbäck B
    Respir Med; 2012 Jul; 106(7):980-8. PubMed ID: 22498109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.
    Swanney MP; Ruppel G; Enright PL; Pedersen OF; Crapo RO; Miller MR; Jensen RL; Falaschetti E; Schouten JP; Hankinson JL; Stocks J; Quanjer PH
    Thorax; 2008 Dec; 63(12):1046-51. PubMed ID: 18786983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prevalence of chronic obstructive pulmonary disease (COPD) in Germany. Results of the BOLD study].
    Geldmacher H; Biller H; Herbst A; Urbanski K; Allison M; Buist AS; Hohlfeld JM; Welte T
    Dtsch Med Wochenschr; 2008 Dec; 133(50):2609-14. PubMed ID: 19052996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old.
    Geijer RM; Sachs AP; Hoes AW; Salomé PL; Lammers JW; Verheij TJ
    Fam Pract; 2005 Oct; 22(5):485-9. PubMed ID: 15964866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of lung function and its decline in mild to moderate COPD in association with gender: results from the Euroscop study.
    Watson L; Vonk JM; Löfdahl CG; Pride NB; Pauwels RA; Laitinen LA; Schouten JP; Postma DS;
    Respir Med; 2006 Apr; 100(4):746-53. PubMed ID: 16199147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence of COPD in Iceland--the BOLD study].
    Benediktsdóttir B; Gudmundsson G; Jörundsdóttir KB; Vollmer W; Gíslason T
    Laeknabladid; 2007 Jun; 93(6):471-7. PubMed ID: 17541146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal symptoms, airway obstruction and disease severity in chronic obstructive pulmonary disease.
    Hurst JR; Kuchai R; Michael P; Perera WR; Wilkinson TM; Wedzicha JA
    Clin Physiol Funct Imaging; 2006 Jul; 26(4):251-6. PubMed ID: 16836700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
    Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
    Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-second spirometry for detection of airway obstruction: a population-based study in Austria.
    Lamprecht B; Schirnhofer L; Tiefenbacher F; Kaiser B; Buist SA; Studnicka M; Enright P
    Am J Respir Crit Care Med; 2007 Sep; 176(5):460-4. PubMed ID: 17556719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow and volume responses after routine salbutamol reversibility testing in mild to very severe COPD.
    Schermer T; Heijdra Y; Zadel S; van den Bemt L; Boonman-de Winter L; Dekhuijzen R; Smeele I
    Respir Med; 2007 Jun; 101(6):1355-62. PubMed ID: 17098407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
    Kömüs N; Tertemiz KC; Sevinç C
    Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.